A randomized, blinded, comparator-controlled trial investigating a 28-day course of Lyrica in participants with knee osteoarthritis who exhibit neuropathic pain, compared with a 28-day course of acetaminophen.

Trial Profile

A randomized, blinded, comparator-controlled trial investigating a 28-day course of Lyrica in participants with knee osteoarthritis who exhibit neuropathic pain, compared with a 28-day course of acetaminophen.

Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Jun 2017

At a glance

  • Drugs Pregabalin (Primary) ; Paracetamol
  • Indications Neuropathic pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Jun 2017 Primary endpoints of WOMAC Pain scores and PainDETECT scores has been met, according to results presented at the 18th Annual Congress of the European League.
    • 17 Jun 2017 Primary endpoint of pressure pain thresholds has been met, according to results presented at the 18th Annual Congress of the European League Against Rheumatism.
    • 17 Jun 2017 Primary endpoint of cold pain thresholds has not been met, according to results presented at the 18th Annual Congress of the European League Against Rheumatism.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top